IOL Chemicals & Pharmaceuticals jumped 10.48% to Rs 296.45, rising for the fourth consecutive session.
The stock has surged 26.42% in last four trading sessions from its previous closing low of Rs 234.50 registered on 19 February 2020.Shares of IOL Chemicals & Pharmaceuticals were in demand after media houses reported that shutdown in China's Hubei province is boosting prices of non prescription painkiller. IOL Chemicals & Pharmaceuticals is reportedly world's largest producer of ibuprofen. Ibuprofen is a synthetic compound used widely as an analgesic and anti-inflammatory drug.
On a standalone front, IOL Chemicals & Pharmaceuticals reported a 19.2% jump in net profit to Rs 98.01 crore on a 6.9% rise in net sales to Rs 511.25 crore in Q3 December 2019 over Q3 December 2018.
IOL Chemicals & Pharmaceuticals is one of the leading generic pharmaceuticals companies and is significant player in the speciality chemicals space.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app